Elevance Health
ELV · NYSE
About ELV
- Employees
- 96,129
- Headquarters
- Indianapolis, Indiana
- Listed
- Oct 30, 2001
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- elevancehealth.com
ELV key statistics
- Market cap
- 95.46B
- Price-earnings ratio
- 19.06
- Dividend yield
- 1.59%
- Average volume
- 1.21M
- Volume
- 1.55M
- Open price
- $432.87
- High today
- $440.67
- Low today
- $431.09
- 52 Week high
- $436.24
- 52 Week low
- $274.84
Elevance Health (ELV) at a glance
Elevance Health (ELV) last traded at $440.18, with a market cap of 95.46B, a price-to-earnings ratio of 19.06 and a dividend yield of 1.59%.
Today the stock has traded between $431.09 and $440.67. The current price is 2.1% above the day's low and 0.1% below its high.
Volume so far is 1.55M shares, above the average of 1.21M shares a day.
Over the past year Elevance Health has ranged from $274.84 to $436.24, and now sits 102% of the way up that range.
Elevance Health met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $7.45 per share against an estimate of $6.27.
The average analyst price target is $457.94, 4.0% above the current price, from 19 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy73.7%
- Hold26.3%
- Sell0.0%
- Low
- $396.93
- Now
- $440.18
- High
- $516.60
ELV earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 11.0% on average.
- Q3 FY24: reported $8.37 per share against an estimate of $9.76
- Q4 FY24: reported $3.84 per share against an estimate of $3.83
- Q1 FY25: reported $11.97 per share against an estimate of $11.50
- Q2 FY25: reported $8.84 per share against an estimate of $9.04
- Q3 FY25: reported $6.03 per share against an estimate of $4.98
- Q4 FY25: reported $3.33 per share against an estimate of $3.13
- Q1 FY26: reported $12.58 per share against an estimate of $10.93
- Q2 FY26: reported $7.45 per share against an estimate of $6.27
ELV news
- Press releaseGlobe Newswire
- Press releasePRNewswire
Did Elevance Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseBusiness Wire
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
- Press releaseBusiness Wire
Elevance Health’s Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
- Piero Cingari
Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High
- Evette Mitkov
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
10 Health Care Stocks Whale Activity In Today’s Session
- Chris Katje
Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2
Similar companies
Companies in the same industry as Elevance Health
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.